BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17520872)

  • 1. Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
    Monteleone G; Caprioli F
    Curr Opin Investig Drugs; 2007 May; 8(5):423-8. PubMed ID: 17520872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ecabet sodium enema on steroid resistant or steroid dependent ulcerative colitis.
    Iizuka M; Itou H; Konno S; Shirasaka T; Horie Y; Shindo K; Watanabe S
    Gut; 2006 Oct; 55(10):1523. PubMed ID: 16966708
    [No Abstract]   [Full Text] [Related]  

  • 3. Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
    Takagi T; Naito Y; Okuda T; Uchiyama K; Adachi S; Mizushima K; Handa O; Kokura S; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1259-65. PubMed ID: 20594253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats.
    Noto T; Yamada H; Inui T; Okuyama K; Watanable A; Kimura I; Nagasaki M
    Dig Dis Sci; 2005 May; 50(5):922-7. PubMed ID: 15906769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecabet sodium: a potential new agent in the management of distal colitis.
    Lawrance IC
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1182-4. PubMed ID: 20594242
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study.
    Kono T; Nomura M; Kasai S; Kohgo Y
    Am J Gastroenterol; 2001 Mar; 96(3):793-7. PubMed ID: 11280553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.
    Hammond A; Andus T; Gierend M; Ecker KW; Scholmerich J; Herfarth H;
    Hepatogastroenterology; 2004; 51(59):1345-9. PubMed ID: 15362749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute adrenal insufficiency after stopping prolonged corticotherapy with betnesol enemas for ulcerative colitis].
    Bili H; Algayres JP; Revel F; Coutant G; Daly JP
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1113-4. PubMed ID: 10051992
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical corticosteroids in ulcerative colitis.
    Drug Ther Bull; 1975 Jan; 13(2):5-7. PubMed ID: 1212926
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ; Bemelman WA; Stokkers PC
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enema volume as an important factor in successful topical corticosteroid treatment of colitis.
    Swarbrick ET; Loose H; Lennard-Jones JE
    Proc R Soc Med; 1974 Aug; 67(8):753-4. PubMed ID: 4417491
    [No Abstract]   [Full Text] [Related]  

  • 12. Is keeping the colon the ultimate marker of success in ulcerative colitis?
    Nguyen GC; Prather CM
    Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of catarrhal and catarrho-erosive colitis with Repredsol (a new combination drug for topical application)].
    Sirakov P
    Vutr Boles; 1973; 12(4):92-7. PubMed ID: 4770082
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
    Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of ulcerative colitis. Some reflections.
    Banks C; Forbes A
    Dig Liver Dis; 2007 Apr; 39(4):338-41. PubMed ID: 17317345
    [No Abstract]   [Full Text] [Related]  

  • 16. Re-epithelialization of squamous epithelium for a radiation-induced rectal ulcer while giving an ecabet sodium enema.
    Chino A; Kishihara T; Uragami N; Ishiyama A; Ogawa T; Hoshino E; Igarashi M; Fujita R
    Dig Endosc; 2009 Jan; 21(1):56-8. PubMed ID: 19691805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.
    Wright JP; Winter TA; Candy S; Marks IS
    Dig Dis Sci; 1999 Sep; 44(9):1899-901. PubMed ID: 10505732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enema therapy for ulcerative colitis patients].
    Furuta R; Kusugami K; Goto H
    Nihon Rinsho; 2005 May; 63(5):845-9. PubMed ID: 15881180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patients prefer foam].
    MMW Fortschr Med; 2007 May; 149(21):48. PubMed ID: 17668735
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of gastro-retentive forms of ecabet sodium in the treatment of gastric ulcer in rats.
    Kim JY; Bae HJ; Choi J; Lim JR; Kim SW; Lee SH; Park ES
    Arch Pharm Res; 2014 Aug; 37(8):1053-62. PubMed ID: 24254934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.